PGAM5调节巨细胞极化,通过NF-κB通路加剧COPD中的炎症
Yu Zheng1,2, Yujie Wang1, Jia Li2
1Department of Respiratory Medicine, The second Affiliated Hospital, Hainan Medical University, Haikou, 570100, People's Republic of China.
糖酸突变酶5 (PGAM5) 通过激活NF-κB通路和M1巨分化,促进慢性阻塞性肺病 (COPD). 沉默PGAM5扭转了这些影响,为COPD提供了治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 肺部病理学 肺部病理学
背景情况:
- 慢性阻塞性肺病 (COPD) 构成了全球重大健康威胁.
- 在COPD肺组织中升的糖酸突变酶5 (PGAM5) 表达与疾病严重程度相关.
- 在COPD病原发生过程中,PGAM5的确切分子机制尚未完全理解.
研究的目的:
- 为了研究PGAM5在COPD病变发生中的作用.
- 为了阐明PGAM5在巨细胞中影响的分子通路.
主要方法:
- 通过使用小鼠膜巨细胞 (MH-S) 建立了COPD模型.
- 采用流式细胞计,ELISA和西部斑点分析巨细胞极化,炎症性细胞因子分泌和NF-κB通路.
- 评估了PGAM5表达的变化及其下游影响.
主要成果:
- PGAM5显著增强了M1巨细胞的两极分化.
- PGAM5诱导了促炎因素的分泌,包括IL-1β和TNF-α.
- 通过结合和激活ASK1,PGAM5激活了NF-κB通路,PGAM5沉默反转了这一效应.
结论:
- 在PGAM5上调 p-ASK1T838,激活NF-κB通路.
- PGAM5驱动M1巨细胞的两极化和促炎性细胞因子的产生.
- 准PGAM5为COPD预防和治疗提供了一个有前途的战略.
更多相关视频
07:45Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis
Published on: November 28, 2015
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation
